Assignee
PURECODON HONG KONG BIOPHARMA LTD
CN·5 granted patents·2 pending applications·3 citations·filing 2021–2025
Top patents by PatentIndex Score
7 records- 0184US11634727B2Recombinant nucleic acid molecule of transcriptional circular RNA and its application in protein expressionPURECODON HONG KONG BIOPHARMA LTD·Filed 2021·Granted Apr 25, 2023·1 cites·8 claims
- 0281US11786609B2Lipid compound as well as lipid vector, nucleic acid lipid nanoparticle composition, and pharmaceutical preparation comprising the samePURECODON HONG KONG BIOPHARMA LTD·Filed 2022·Granted Oct 17, 2023·1 cites·16 claims
- 0381US11690922B2Lipid compound as well as lipid carrier, nucleic acid lipid nanoparticle composition and pharmaceutical preparation containing samePURECODON HONG KONG BIOPHARMA LTD·Filed 2022·Granted Jul 4, 2023·1 cites·18 claims
- 0462US12331290B2Recombinant nucleic acid molecule and application thereof in preparation of circular RNAPURECODON HONG KONG BIOPHARMA LTD·Filed 2022·Granted Jun 17, 2025·0 cites·14 claims
- 0561US2025270544A1Recombinant nucleic acid molecule and application thereof in preparation of circular rnaPURECODON HONG KONG BIOPHARMA LTD·Filed 2025·Application pending·0 cites
- 0654US12054722B2Recombinant nucleic acid molecule based on point mutation of translation initiation element and use thereof in preparation of circular RNAPURECODON HONG KONG BIOPHARMA LTD·Filed 2022·Granted Aug 6, 2024·0 cites·14 claims
- 0754US2023119715A1Levenshtein distance-based ires screening method and polynucleotide screened based on samePURECODON HONG KONG BIOPHARMA LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PURECODON HONG KONG BIOPHARMA LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →